Elena G.
- Country
- Romania
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 117 partner sites.
Specializations
Oncology Focus
This investigator specializes in the treatment of non-small cell lung cancer (NSCLC), with particular emphasis on advancing therapeutic approaches for patients with specific molecular profiles.
- Advanced NSCLC Management
- PD-L1 Expression Analysis
- Immunotherapy Combinations
Their research interests center on evaluating novel therapeutic combinations in previously untreated lung cancer patients.
Immunotherapy Research
The investigator's work focuses on studying immune checkpoint inhibitors and their combinations in oncology treatment, particularly examining novel therapeutic approaches.
- Checkpoint Inhibitor Therapy
- Combination Treatment Strategies
- First-line Treatment Protocols
Their expertise extends to investigating innovative immunotherapy combinations for cancer treatment.
Biomarker Studies
The investigator demonstrates particular interest in PD-L1 expression analysis and its role in treatment selection for lung cancer patients.
- PD-L1 Testing
- Biomarker-Driven Treatment
- Patient Stratification
Their research emphasizes the importance of molecular profiling in personalizing cancer treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.